Mirum Pharmaceuticals, Inc.
MIRM- 交易所
- Nasdaq
- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
近 90 天,Mirum Pharmaceuticals, Inc. 內部人申報 0 筆公開市場買進、6 筆賣出;2026 年第 3 季末有 316 家機構在 13F 申報持有,市值合計 $61.6 億;沒有大師持有。
持有 MIRM 5% 以上的大股東
最新一份 Schedule 13D 或 13G 申報持有 Mirum Pharmaceuticals, Inc. 5% 以上的持有人,依持股比例由大到小;變化是跟這位持有人的上一份申報比。
| 持有人 | 最新表單 | 持股 | 變化 | 首次申報 | 最新申報 | 原文 |
|---|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13G/A | 14.30%股數 2,274 萬 | +3.30 個百分點原本 11.00% | 2024/7/104 份 | 2025/5/14 | SEC |
| Janus Henderson Group PLC | 13G/A | 8.50%股數 553.7 萬 | −1.20 個百分點原本 9.70% | 2025/2/1410 份 | 2026/11/16 | SEC |
| Frazier Life Sciences IX, L.P. | 13D/A | 6.80%股數 410.8 萬 | −0.80 個百分點原本 7.60% | 2022/8/166 份 | 2026/1/27 | SEC |
| FMR LLC | 13G | 6.20%股數 377.8 萬 | 新申報 | 2026/8/61 份 | 2026/8/6 | SEC |
| BlackRock, Inc. | 13G/A | 5.70%股數 346.6 萬 | – | 2024/10/223 份 | 2026/4/27 | SEC |
持股是每位持有人最新一份申報的數字。最後一份是舊格式(2024 年 12 月 18 日以前)的持有人沒有持股比例紀錄,不列在這裡;公司被收購或下市之後,持有人通常就不再申報。
13D 與 13G 申報
Mirum Pharmaceuticals, Inc. 的 54 份 Schedule 13D、13G 申報,由新到舊,包括沒有持股比例的舊格式申報。
| 申報時間(美東) | 申報人 | 表單 | 持股 | 變化 | 事件日 | 原文 |
|---|---|---|---|---|---|---|
| 2026/11/1612:24 ET | Janus Henderson Group PLC | 13G/A | 8.50%股數 553.7 萬 | −1.20 個百分點原本 9.70% | 2026/9/30 | SEC |
| 2026/8/1312:47 ET | Janus Henderson Group PLC | 13G/A | 9.70%股數 590.9 萬 | −2.10 個百分點原本 11.80% | 2026/6/30 | SEC |
| 2026/8/610:33 ET | FMR LLC等 2 位 | 13G | 6.20%股數 377.8 萬 | 新申報 | 2026/6/30 | SEC |
| 2026/4/2716:12 ET | BlackRock, Inc. | 13G/A | 5.70%股數 346.6 萬 | – | 2026/3/31 | SEC |
| 2026/3/2710:52 ET | Vanguard Group Inc | 13G/A | 0.00%股數 0 | –低於 5% | 2026/3/13 | SEC |
| 2026/2/1716:33 ET | Janus Henderson Group PLC | 13G/A | 11.80%股數 606.5 萬 | +1.20 個百分點原本 10.60% | 2025/12/31 | SEC |
| 2026/2/1313:09 ET | Eventide Asset Management, LLC等 3 位 | 13G/A | 4.10%股數 209.4 萬 | −1.33 個百分點原本 5.43%低於 5% | 2025/12/31 | SEC |
| 2026/1/2716:12 ET | Frazier Life Sciences IX, L.P.等 17 位 | 13D/A | 6.80%股數 410.8 萬 | −0.80 個百分點原本 7.60% | 2026/1/23 | SEC |
| 2025/12/512:46 ET | Janus Henderson Group PLC | 13G/A | 10.60%股數 544.5 萬 | +0.60 個百分點原本 10.00% | 2025/11/28 | SEC |
| 2025/11/1416:14 ET | Biotechnology Value Fund L P等 10 位 | 13G/A | 3.00%股數 149.5 萬 | –低於 5% | 2025/9/30 | SEC |
| 2025/11/1412:03 ET | Janus Henderson Group PLC | 13G/A | 10.00%股數 499.8 萬 | −0.60 個百分點原本 10.60% | 2025/9/30 | SEC |
| 2025/11/417:26 ET | Frazier Life Sciences IX, L.P.等 14 位 | 13D/A | 7.60%股數 373.5 萬 | 0.00 個百分點原本 7.60% | 2025/11/1 | SEC |
| 2025/8/2017:17 ET | Frazier Life Sciences IX, L.P.等 20 位 | 13D/A | 7.60%股數 373.5 萬 | – | 2025/8/18 | SEC |
| 2025/8/1411:15 ET | Janus Henderson Group PLC | 13G/A | 10.60%股數 523.6 萬 | +0.30 個百分點原本 10.30% | 2025/6/30 | SEC |
| 2025/6/611:59 ET | Janus Henderson Group PLC | 13G/A | 10.30%股數 508.2 萬 | +0.60 個百分點原本 9.70% | 2025/5/30 | SEC |
| 2025/5/1515:32 ET | Janus Henderson Group PLC | 13G/A | 9.70%股數 477.5 萬 | −0.40 個百分點原本 10.10% | 2025/3/31 | SEC |
| 2025/5/1411:59 ET | Janus Henderson Group PLC等 2 位 | 13G/A | 14.30%股數 2,274 萬 | +3.30 個百分點原本 11.00% | 2025/3/31 | SEC |
| 2025/5/710:57 ET | Janus Henderson Group PLC | 13G/A | 10.10%股數 499.9 萬 | +0.60 個百分點原本 9.50% | 2025/4/30 | SEC |
| 2025/2/1412:11 ET | Janus Henderson Group PLC | 13G/A | 9.50%股數 458.2 萬 | – | 2024/12/31 | SEC |
| 2025/2/1412:09 ET | Janus Henderson Group PLC等 2 位 | 13G/A | 11.00%股數 1,712 萬 | – | 2024/12/31 | SEC |
| 2025/2/1412:06 ET | Eventide Asset Management, LLC等 3 位 | 13G/A | 5.43%股數 260.7 萬 | – | 2024/12/31 | SEC |
| 2025/2/1412:01 ET | Eventide Asset Management, LLC等 3 位 | 13G/A | 3.46%股數 222.0 萬 | –低於 5% | 2024/12/31 | SEC |
| 2024/11/14 | Eventide Asset Management, LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/11/14 | Janus Henderson Group PLC | 13G/A舊制 | – | – | – | SEC |
| 2024/11/14 | Biotechnology Value Fund L P | 13G/A舊制 | – | – | – | SEC |
| 2024/11/12 | BlackRock, Inc. | 13G/A舊制 | – | – | – | SEC |
| 2024/10/22 | BlackRock, Inc. | 13G/A舊制 | – | – | – | SEC |
| 2024/7/10 | Janus Henderson Group PLC | 13G舊制 | – | 新申報 | – | SEC |
| 2024/2/14 | Eventide Asset Management, LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/2/13 | Vanguard Group Inc | 13G舊制 | – | 新申報 | – | SEC |
| 2024/1/3114:08 ET | BlackRock Inc. | 13G舊制 | – | – | – | SEC |
| 2023/12/29 | New Enterprise Associates 16, L.P. | 13D/A舊制 | – | – | – | SEC |
| 2023/9/18 | Biotechnology Value Fund L P | 13G舊制 | – | 新申報 | – | SEC |
| 2023/9/5 | Frazier Life Sciences IX, L.P. | 13D/A舊制 | – | – | – | SEC |
| 2023/6/23 | New Enterprise Associates 16, L.P. | 13D/A舊制 | – | – | – | SEC |
| 2023/5/3 | Flynn James E | 13G/A舊制 | – | – | – | SEC |
| 2023/4/14 | Frazier Life Sciences IX, L.P. | 13D/A舊制 | – | – | – | SEC |
| 2023/3/814:15 ET | BlackRock Inc. | 13G/A舊制 | – | – | – | SEC |
| 2023/2/14 | Eventide Asset Management, LLC | 13G舊制 | – | 新申報 | – | SEC |
| 2023/2/14 | Rock Springs Capital Management LP | 13G/A舊制 | – | – | – | SEC |
| 2023/2/10 | Flynn James E | 13G/A舊制 | – | – | – | SEC |
| 2023/2/316:27 ET | BlackRock Inc. | 13G舊制 | – | 新申報 | – | SEC |
| 2022/12/1 | RiverVest Venture Fund IV, L.P. | 13D/A舊制 | – | – | – | SEC |
| 2022/9/12 | Flynn James E | 13G/A舊制 | – | – | – | SEC |
| 2022/8/18 | Novo Holdings A/S | 13D/A舊制 | – | – | – | SEC |
| 2022/8/16 | Frazier Life Sciences IX, L.P. | 13D/A舊制 | – | – | – | SEC |
| 2022/8/2 | Novo Holdings A/S | 13D/A舊制 | – | – | – | SEC |
| 2022/4/8 | Novo Holdings A/S | 13D/A舊制 | – | – | – | SEC |
| 2022/2/15 | Rock Springs Capital Management LP | 13G/A舊制 | – | – | – | SEC |
| 2022/2/11 | Flynn James E | 13G/A舊制 | – | – | – | SEC |
Form 144:內部人預計賣出
高階主管、董事與其他關係人預計賣出 Mirum Pharmaceuticals, Inc. 股票的 59 份通知,由新到舊。
| 申報時間(美東) | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|
| 2026/11/1616:04 ET | Saira Ramasastry董事 | 2,000 | $18.5 萬 | 2026/11/1610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/11/1208:34 ET | Laura Brege董事 | 1.42 萬 | $133.5 萬 | 2026/11/11 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/11/420:41 ET | Joanne Quan前高階主管 | 1.47 萬 | $142.4 萬 | 2026/11/4 | Morgan Stanley Smith Barney LLC | SEC |
| 2026/11/416:26 ET | Christopher Peetz高階主管 · 董事 | 2.00 萬 | $180.0 萬 | 2026/11/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/9/1516:18 ET | Eric Bjerkholt高階主管 | 9,943 | $97.8 萬 | 2026/9/14 | Morgan Stanley Smith Barney LLC | SEC |
| 2026/9/216:06 ET | Jolanda Marie Howe高階主管 | 658 | $6.58 萬 | 2026/9/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/9/116:12 ET | Christopher Peetz高階主管 · 董事 | 3.00 萬 | $296.0 萬 | 2026/9/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/8/1817:24 ET | Jolanda Marie Howe高階主管 | 4.00 萬 | $400.0 萬 | 2026/8/18 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/8/1116:11 ET | Eric Bjerkholt高階主管 | 6,001 | $60.0 萬 | 2026/8/11 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/8/1016:17 ET | Christopher Peetz高階主管 · 董事 | 2.00 萬 | $197.8 萬 | 2026/8/1010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/8/316:07 ET | Jolanda Marie Howe高階主管 | 1,840 | $19.4 萬 | 2026/8/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/7/616:10 ET | Christopher Peetz高階主管 · 董事 | 2.00 萬 | $244.5 萬 | 2026/7/610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/7/616:09 ET | Eric Bjerkholt高階主管 | 5,000 | $61.1 萬 | 2026/7/610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/7/117:24 ET | Jolanda Marie Howe高階主管 | 2,721 | $32.7 萬 | 2026/7/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/1716:01 ET | Jolanda Marie Howe高階主管 | 2,594 | $26.4 萬 | 2026/6/1710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/816:20 ET | Eric Bjerkholt高階主管 | 5,000 | $46.9 萬 | 2026/6/810b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/117:33 ET | Christopher Peetz高階主管 · 董事 | 3.00 萬 | $287.5 萬 | 2026/6/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/116:04 ET | Saira Ramasastry董事 | 3,977 | $39.8 萬 | 2026/6/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/5/1516:07 ET | Saira Ramasastry董事 | 2,000 | $21.9 萬 | 2026/5/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/4/1516:11 ET | Saira Ramasastry董事 | 2,000 | $19.4 萬 | 2026/4/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/3/1719:03 ET | Eric Bjerkholt高階主管 | 7,287 | $67.5 萬 | 2026/3/1610b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| 2026/3/1719:00 ET | Joanne Quan高階主管 | 7,287 | $67.5 萬 | 2026/3/1610b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| 2026/3/1718:58 ET | Peter Radovich高階主管 | 1.65 萬 | $153.0 萬 | 2026/3/1610b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| 2026/3/1718:55 ET | Jolanda Howe高階主管 | 4,732 | $43.8 萬 | 2026/3/1610b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| 2026/3/1718:50 ET | Christopher Peetz高階主管 · 董事 | 4.10 萬 | $379.7 萬 | 2026/3/1610b5-1 | Morgan Stanley Smith Barney LLC | SEC |
只列最新的 25 份。看 MIRM 近 12 個月的全部通知